Ibandronic Acid: Clinical Trials

28 trials of Ibandronic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 2 terminated, 1 withdrawn. 28 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 428Completed 25, Terminated 2, Withdrawn 1

Follow Ibandronic Acid: new trials by email Literature Review of Ibandronic Acid trials Research Report on Ibandronic Acid

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation
Treated with Ibandronic acid as per protocol - Cirrhosis
Phase 4CompletedDr. Ashish Kumar472012-08-012014-09-26
Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids
Ibandronate, Placebo - Rheumatoid Arthritis, Osteoporosis
Phase 4CompletedYeong-Wook Song1672010-04-012014-11-19
Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis
Ibandronate (Bondronat) - Lung Cancer
Phase 4TerminatedChinese Society of Lung Cancer202007-07-012016-02-17
A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
ibandronate [Bonviva/Boniva], Alendronate - Post-Menopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche8012007-07-012011-06-17
Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus
Ibandronate+alfacalcidol+calcium, placebo ibandronate+alfacalcidol+calcium - Systemic Lupus Erythematosus
Phase 4CompletedChinese University of Hong Kong402007-04-012012-02-13
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Ibandronate (SB743830HD) - Osteoporosis, Postmenopausal
Phase 4CompletedGlaxoSmithKline3652007-03-222018-06-06
ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
ibandronate [Bonviva/Boniva] - Post Menopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche5612006-08-012016-11-10
A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer
Ibandronate - Pain; Bone Neoplasms; Neoplasm Metastasis
Phase 4CompletedHoffmann-La Roche1822006-07-012015-09-17
The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density
ibandronate, teriparatide - Osteoporosis
Phase 4TerminatedPapageorgiou General Hospital192006-07-012014-10-29
SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
ibandronate [Bonviva/Boniva] - Post Menopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche5962006-07-012015-08-18
A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
Placebo, ibandronate - Postmenopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche1402006-05-012016-05-12
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Risedronate, ibandronate [Bonviva/Boniva] - Post Menopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche3562006-05-012016-08-01
A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
Ibandronate - Postmenopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche7162006-04-012016-10-24
Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
ibandronate, calcium and vitamin D, placebo,calcium and vitamin D - Osteoporosis, Postmenopausal
Phase 4CompletedCharite University, Berlin, Germany702006-03-012009-01-28
BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
ibandronate [Bonviva/Boniva] - Postmenopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche5852006-03-012016-11-02
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
Placebo, Vitamin D and calcium supplementation, ibandronate [Bonviva/Boniva] - Post Menopausal Osteoporosis
Phase 4CompletedHoffmann-La Roche672006-02-012016-05-02
A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia
Placebo, ibandronate [Bonviva/Boniva] - Post-Menopausal Osteopenia
Phase 4CompletedHoffmann-La Roche1602005-12-012016-01-11
A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo
ibandronate, Placebo - Osteoporosis
Phase 4CompletedHoffmann-La Roche982005-08-012016-11-08
A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo
ibandronate - Osteoporosis
Phase 4CompletedGlaxoSmithKline1002005-08-012016-10-31
Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate
Ibandronate, Alendronate - Osteoporosis
Phase 4CompletedGlaxoSmithKline3002005-04-012017-05-30

Showing 20 of 28. Sign in to see all of them.

Conditions studied

Osteoporosis, Postmenopausal (16)  ·  Osteoporosis (7)  ·  Bone Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Pain (2)  ·  Arthritis, Rheumatoid (1)  ·  Bone Diseases, Metabolic (1)  ·  Fibrosis (1)  ·  HIV Infections (1)  ·  Lung Neoplasms (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Spinal Fractures (1)

Sponsors

Hoffmann-La Roche (18)  ·  GlaxoSmithKline (3)  ·  Charite University, Berlin, Germany (1)  ·  Chinese Society of Lung Cancer (1)  ·  Chinese University of Hong Kong (1)  ·  Dr. Ashish Kumar (1)  ·  Germans Trias i Pujol Hospital (1)  ·  Papageorgiou General Hospital (1)  ·  Yeong-Wook Song (1)

Countries

United States (12)  ·  Hungary (4)  ·  Belgium (3)  ·  France (3)  ·  Germany (3)  ·  Mexico (3)  ·  Poland (3)  ·  Spain (3)  ·  Brazil (2)  ·  China (2)  ·  Czechia (2)  ·  Denmark (2)  ·  Greece (2)  ·  Italy (2)  ·  Norway (2)

Top investigators

Dieter Felsenberg, Prof. Dr. (1)  ·  Edmund K Li, MD (1)  ·  Efstathios Mitsopoulos, MD (1)  ·  Eugenia Negredo, MD,PhD (1)  ·  Yilong Wu, MD (1)

Results publications

PMID 20964867, PMID 21703900, PMID 28161119, PMID 34231877

NIH funding

2005 (1)